Results 171 to 180 of about 31,703 (224)

Recent Advancements in the Therapeutic Landscape of IgA Nephropathy and the Impact of Dual Blockers: Telitacicept. [PDF]

Kidney Med
Munisamy Selvam KK, Feng C, Dong S.
europepmc   +1 more source

Correlation of foot process effacement with clinicopathological features and short-term prognosis in IgA nephropathy. [PDF]

Ann Med
Wang Y, Yang Y, Wen X, Yi L, Zeng F, Zhou B, Wang L, Yan W, Ren D, Xu S, Li Y, Liu D, Luo K, Jiang H, Xu G.   +14 more
europepmc   +1 more source

The role of mesenchymal stem cells in IgA nephropathy: current evidence and future directions. [PDF]

Stem Cell Res Ther
Liu Y, Zhao Y, Xie J, Chen J, Yao K, Chen W, Zheng L, Zhou T.   +7 more
europepmc   +1 more source

Impact of crescents on the immunosuppression treatment of IgA nephropathy. [PDF]

Ren Fail
Tang Y, Liao Y, Su L, Mei J, Dai C, Nie S, Ou J.   +6 more
europepmc   +1 more source

Case Report: Spinal muscular atrophy with IgA nephropathy: a coincidence or association? [PDF]

Front Pediatr
Gu Y, Wang L, Yuan X, Han Y, Han P, Cui J, Wang X, Huang Y, Zhang L, Li C.   +9 more
europepmc   +1 more source

Searching for IgA nephropathy candidate genes: genetic studies combined with high throughput innovative investigations

, 2007
SCOLARI, Francesco, EUROPEAN IGA NEPHROPATHY CONSORTIUM, CERULLO G, TORRES DD, ZAZA G, GHIGGERI GM, AMOROSO A, COX S, BISCEGLIA L, FRASCÁ G, SCHENA FP   +10 more
core  

Corrigendum to "Is childhood IgA nephropathy different from adult IgA nephropathy? A narrative review". [PDF]

Can J Kidney Health Dis
europepmc   +1 more source